The changing epidemiology of Clostridioides difficile infection and the NAP1/027 strain in two Québec hospitals: a 17-year time-series study.
In: Antimicrobial stewardship & healthcare epidemiology : ASHE, Jg. 4 (2024-06-04), Heft 1, S. e99
Online
academicJournal
Zugriff:
Objective: To describe the epidemiology of healthcare-associated Clostridioides difficile infection (HA-CDI) in two Québec hospitals in Canada following the 2003 epidemic and to evaluate the impact of antibiotic stewardship on the incidence of HA-CDI and the NAP1/027 strain.
Design: Time-series analysis.
Setting: Two Canadian tertiary care hospitals based in Montréal, Québec.
Patients: Patients with a positive assay for toxigenic C. difficile were identified through infection control surveillance. All cases of HA-CDI, defined as symptoms occurring after 72 hours of hospital admission or within 4 weeks of hospitalization, were included.
Methods: The incidence of HA-CDI and antibiotic utilization from 2003 to 2020 were analyzed with available C. difficile isolates. The impact of antibiotic utilization on HA-CDI incidence was estimated by a dynamic regression time-series model. Antibiotic utilization and the proportion of NAP1/027 strains were compared biannually for available isolates from 2010 to 2020.
Results: The incidence of HA-CDI decreased between 2003 and 2020 at both hospitals from 26.5 cases per 10,000 patient-days in 2003 to 4.9 cases per 10,000 patient-days in 2020 respectively. Over the study period, there were an increase in the utilization of third-generation cephalosporins and a decrease in usage of fluoroquinolones and clindamycin. A decrease in fluoroquinolone utilization was associated with a significant decrease in HA-CDI incidence as well as decrease in the NAP1/027 strain by approximately 80% in both hospitals.
Conclusions: Decreased utilization of fluoroquinolones in two Québec hospitals was associated with a decrease in the incidence of HA-CDI and a genotype shift from NAP1/027 to non-NAP1/027 strains.
Competing Interests: YL received salary support from the Fonds de Recherche du Québec outside of this work. VGL received consulting fees from Ferring Inc., Merck Inc., and Xediton Pharmaceuticals Inc. outside of this work. All other authors report no competing interests.
(© The Author(s) 2024.)
| Titel: |
The changing epidemiology of Clostridioides difficile infection and the NAP1/027 strain in two Québec hospitals: a 17-year time-series study.
|
|---|---|
| Autor/in / Beteiligte Person: | Couture, S ; Frenette, C ; Schiller, I ; Alfaro, R ; Dendukuri, N ; Thirion, D ; Longtin, Y ; Loo, VG |
| Link: | |
| Zeitschrift: | Antimicrobial stewardship & healthcare epidemiology : ASHE, Jg. 4 (2024-06-04), Heft 1, S. e99 |
| Veröffentlichung: | [Cambridge] : Cambridge University Press, [2021]-, 2024 |
| Medientyp: | academicJournal |
| ISSN: | 2732-494X (electronic) |
| DOI: | 10.1017/ash.2024.95 |
| Sonstiges: |
|